期刊文献+

C-kit受体和CD_(34)在急性髓系白血病中的表达与化疗疗效关系

Study on Expression of C-kit Receptor and CD_(34) in Acute Myeloid Leukemia and Their Correlation with Chemotherapeutic Effect
下载PDF
导出
摘要 目的:探讨c-kit受体、CD34的表达与化疗疗效的关系。方法:应用流式细胞仪,测定10例正常人和87例急性髓细胞白血病骨髓c-kit受体和CD34的表达。结果:正常人骨髓c-kit受体和CD34表达率分别为0.5%和1.7%。以>20%细胞表达为阳性,患者c-kit受体和CD34阳性率分别为52%和37%、结论:c-kit受体和CD34阳性病例缓解率较低,差异有显著性(P<0.01),c-kit受体及CD34共同表达者疗效尤差(P<0.005)。 Using flow cytometry, expressions of c-kit receptor and CD34 of bone marrow cells in 10 normal subjects and 87 patients with acute myeloid leukemias have been determined and correlation between expressions and chemotherapeutic effect were studied. The results show that expressing rate of c-kit and CD34 normal subjects marrow cells was 0. 5 %, 1. 7 % respectively. According to standard that expression of more than 20% cells is positive,positive rate of c-kit receptor and CD34 in AML was 52%. 37% respectively. the rate of complete remission in c-kit receptor and CD34 positive group was lower than that of negative group,the difference was significant (P<0.01 ). There was the worst chemotherapeutic effect in coexpressions of c-kit receptor and CD34 (P<0.005).
出处 《临床血液学杂志》 CAS 1998年第5期208-210,共3页 Journal of Clinical Hematology
关键词 C-KIT受体 抗原 CD34 髓细胞白血病 药物疗法 C-kit receptor Antigen CD_(34) Myeloid leukemia Chemotherapeutic effect
  • 相关文献

参考文献2

  • 1郑以州.c-kit受体/配体与骨髓造血功能衰竭[J].国外医学(输血及血液学分册),1997,20(6):340-343. 被引量:1
  • 2L. R. Valverde,L. Matutes,N. Farahat,A. Heffernan,K. Owusu-Ankomah,R. Morilla,D. Catovsky,E. Matutes. C-kit receptor (CD0117) expression in acute leukemia[J] 1996,Annals of Hematology(1):11~15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部